Cargando…

EHMTI-0315. AMG 334, the first potent and selective human monoclonal antibody antagonist against the CGRP receptor

Detalles Bibliográficos
Autores principales:	Xu, C, Shi, L, Rao, S, King, C, Sun, H, Zhu, D, Lehto, S, Wild, K, Immke, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182181/ http://dx.doi.org/10.1186/1129-2377-15-S1-G43

Ejemplares similares

EHMTI-0178. CGRP monoclonal antibody LY2951742 for the prevention of migraine: a phase 2, randomized, double-blind, placebo-controlled study
por: Goadsby, P, et al.
Publicado: (2014)

EHMTI-0018. CGRP receptor antagonists attenuate pain behavior induced by cortical spreading depression in freely moving rats
por: Filiz, A, et al.
Publicado: (2014)

EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)

In vitro characterization of AA71, a potent and selective human monoclonal antibody against CGRP receptor
por: Shi, L, et al.
Publicado: (2013)

EHMTI-0239. Effect of chronic paracetamol treatment on the csd-induced cgrp expression in the trigeminal ganglion
por: Yisarakun, W, et al.
Publicado: (2014)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
por: Berman, Gary, et al.
Publicado: (2020)

AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia
por: Lehto, Sonya G., et al.
Publicado: (2015)

EHMTI-0199. CGRP modulates trigeminal ganglionic neuronal excitability in minimally low pH condition
por: Jansri, U, et al.
Publicado: (2014)

Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
por: Vu, Thuy, et al.
Publicado: (2017)

EHMTI-0117. CGRP infusion in awake rats does not increase expression of immediate early genes, c-fos and zif268, in the trigeminal nucleus caudalis
por: Bhatt, DK, et al.
Publicado: (2014)

Evaluation of AMG 076, a potent and selective MCHR1 antagonist, in rodent and primate obesity models
por: Motani, Alykhan S, et al.
Publicado: (2013)

Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
por: Cohen, Fred, et al.
Publicado: (2022)

New CGRP Antagonists
por: Doods, H. N., et al.
Publicado: (2001)

EHMTI-0214. Headache syndromes - known to the unknown?
por: Rao, K, et al.
Publicado: (2014)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014)

EHMTI-0390. The attitude of migraineurs to alternative therapies
por: Csepany, E, et al.
Publicado: (2014)

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
por: Mullin, Kathleen, et al.
Publicado: (2020)

EHMTI-0235. Hemodialysis-related headache
por: Uludüz, D, et al.
Publicado: (2014)

EHMTI-0027. The neuropathic pain in vascular dementia
por: Tertan, D, et al.
Publicado: (2014)

EHMTI-0086. Pure mestrual vestibular migraine
por: Mostardini, C, et al.
Publicado: (2014)

Refractory migraine profile in CGRP‐monoclonal antibodies scenario
por: Silvestro, Marcello, et al.
Publicado: (2021)

EHMTI-0014. A case of ice-pick headache
por: Tertan, D, et al.
Publicado: (2014)

EHMTI-0009. A particular case of cluster headache
por: Tertan, D, et al.
Publicado: (2014)

Inflammatory complications of CGRP monoclonal antibodies: a case series
por: Ray, Jason C., et al.
Publicado: (2021)

EHMTI-0113. Headaches associated with symptomatic epilepsy in adults
por: Atic, S, et al.
Publicado: (2014)

EHMTI-0029. Medicated headache mask
por: Hyson, M
Publicado: (2014)

EHMTI-0281. Frequency of headache in stroke
por: Zaric, N, et al.
Publicado: (2014)

EHMTI-0050. Systemic and cerebral endothelial function in migraine
por: Zaletel, M, et al.
Publicado: (2014)

EHMTI-0081. Use of rotigotine in chronic cluster headache
por: Savi, L, et al.
Publicado: (2014)

EHMTI-0082. Use of IV steroids in cluster headache
por: Savi, L, et al.
Publicado: (2014)

Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonists
por: Johnson, Kirk W., et al.
Publicado: (2022)

EHMTI-0216. Primary headache among adolescents in Albania
por: Kruja, J, et al.
Publicado: (2014)

EHMTI-0171. Headache disorders - current care of physiotherapy?
por: Eder, A, et al.
Publicado: (2014)

EHMTI-0189. Tryptophan-kynurenine metabolism in migraine patients
por: Majláth, Z, et al.
Publicado: (2014)

EHMTI-0131. Clinical features of cluster headache in women
por: Tassorelli, C, et al.
Publicado: (2014)

EHMTI-0370. The performance of the ID-Migraine questionnaire in a Hungarian sample
por: Csepany, E, et al.
Publicado: (2014)

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_24oi0onlm56i9b5h4imrg538hp